#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2189097	F	Growth inhibition of human A549 cells	Homo sapiens	33		cell-based format	Scientific Literature
2.	ALA2189098	F	Growth inhibition of human HepG2 cells	Homo sapiens	33		cell-based format	Scientific Literature
3.	ALA2189099	T	Toxicity in Nu-Foxn1'nu mouse assessed as effect on motor coordination at 10 mg/kg, po administered once daily on day 1 to 10, day 15 to 19 and day 22 to 26 measured during day 58 to 61 post dose by rotarod test	Mus musculus	1		organism-based format	Scientific Literature
4.	ALA2189100	T	Toxicity in Nu-Foxn1'nu mouse assessed as effect on motor coordination at 5 mg/kg, po administered once daily on day 1 to 10, day 15 to 19 and day 22 to 26 measured during day 58 to 61 post dose by rotarod test	Mus musculus	1		organism-based format	Scientific Literature
5.	ALA2189101	F	Antiinflammatory activity against Sprague-Dawley rat assessed as reduction in carrageenan-induced hind paw edema at 5 mg/kg, ip	Rattus norvegicus	1		organism-based format	Scientific Literature
6.	ALA2189102	F	Antiinflammatory activity against Sprague-Dawley rat assessed as reduction in carrageenan-induced hind paw edema at 3 mg/kg, ip	Rattus norvegicus	1		organism-based format	Scientific Literature
7.	ALA2189103	T	Toxicity in human A549 cells xenografted Nu-Foxn1'nu mouse assessed as incidence of overt toxicity at 10 mg/kg, po administered once daily on day 1 to 10, day 15 to 19 and day 22 to 26	Mus musculus	1		organism-based format	Scientific Literature
8.	ALA2189104	F	Antitumor activity against human A549 cells xenografted in Nu-Foxn1'nu mouse assessed as reduction in tumor volume at 10 mg/kg, po administered once daily on day 1 to 10, day 15 to 19 and day 22 to 26	Homo sapiens	1		organism-based format	Scientific Literature
9.	ALA2182909	A	Oral bioavailability in Sprague-Dawley rat at 3 mg/kg by HPLC-MS method	Rattus norvegicus	5		organism-based format	Scientific Literature
10.	ALA2182910	A	AUC (0 to infinity) in Sprague-Dawley rat at 3 mg/kg, po by HPLC-MS method	Rattus norvegicus	3		organism-based format	Scientific Literature
11.	ALA2182913	A	Tmax in Sprague-Dawley rat at 3 mg/kg, po by HPLC-MS method	Rattus norvegicus	3		organism-based format	Scientific Literature
12.	ALA2182915	A	Cmax in Sprague-Dawley rat at 3 mg/kg, po by HPLC-MS method	Rattus norvegicus	3		organism-based format	Scientific Literature
13.	ALA2182916	A	Apparent elimination half life in Sprague-Dawley rat at 3 mg/kg, po by HPLC-MS method	Rattus norvegicus	3		organism-based format	Scientific Literature
14.	ALA2182919	A	AUC (0 to infinity) in Sprague-Dawley rat at 3 mg/kg, iv by HPLC-MS method	Rattus norvegicus	3		organism-based format	Scientific Literature
15.	ALA2182921	A	Volume of distribution at steady state in Sprague-Dawley rat at 3 mg/kg, iv by HPLC-MS method	Rattus norvegicus	3		organism-based format	Scientific Literature
16.	ALA2182922	A	Clearance in Sprague-Dawley rat at 3 mg/kg, iv by HPLC-MS method	Rattus norvegicus	3		organism-based format	Scientific Literature
17.	ALA2182925	A	Apparent elimination half life in Sprague-Dawley rat at 3 mg/kg, iv by HPLC-MS method	Rattus norvegicus	3		organism-based format	Scientific Literature
18.	ALA2182926	P	Solubility in DMA		6		small-molecule physicochemical format	Scientific Literature
19.	ALA2182927	P	Solubility in DMSO		6		small-molecule physicochemical format	Scientific Literature
20.	ALA2182928	F	Antiviral activity against Murine hepatitis virus JHM infected in mouse DBT cells assessed as reduction in N-protein expression at 0.05 to 0.5 uM pre-treated 1 hr before virus infection and measured 24 hrs post infection by immunofluorescent assay	Murine hepatitis virus	1		organism-based format	Scientific Literature